115 results
Page 4 of 6
8-K
EX-99.1
erxvf
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
8-K
EX-1.1
hht8v4sv
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
aq03cyqzazeke nee1gk
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
kdxg4hdt22 3dcpu
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
icj06mfe6yy5vyu880v
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
c6m9hf3pzq8bvg1txv
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
qid zvlhnf1e0xct
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
ugjj2em6ufjo9ll
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
5qdngaosqqka5d986
5 Apr 21
Departure of Directors or Certain Officers
4:49pm